{
  "experiment_info": {
    "experiment_name": "paper_12_Hyaluronan_A",
    "run_number": 2,
    "total_runs": 10,
    "timestamp": "20250624_020624",
    "run_start_time": "2025-06-24T03:11:26.287946",
    "run_end_time": "2025-06-24T03:11:59.119723"
  },
  "inputs": {
    "initial_description": {
      "timestamp": "2025-06-24T03:11:26.287946",
      "data": {
        "description": "During embryonic development, cardiac valves arise at specific regions in the cardiac endothelium that swell up due to enhanced extracellular matrix production (so-called endocardial cushions). An important extracellular matrix component that is produced by the endocardial cells is the glycosaminoglycan hyaluronan. A deficiency in hyaluronan synthesis results in a failure to form endocardial cushions and a loss of their cellularization by a process called endothelial-to-mesenchymal transformation. Expression of the major hyaluronan synthase Has2 is under the influence of both positive and negative regulators. MicroRNA-dependent degradation of Has2 is required to control extracellular hyaluronan levels and thereby the size of the endocardial cushions. In this article, we review the current literature on hyaluronan synthesis during cardiac valve formation and propose that a balanced activity of both positive and negative regulators is required to maintain the critical homeostasis of hyaluronan levels in the extracellular matrix and thereby the size of the endocardial cushions. The activating and inhibitory interactions between microRNA-23, Has2, and hyaluronan are reminiscent of a reaction\u2013diffusion system. Using a mathematical modeling approach we show that the system can produce a confined expression of hyaluronan, but only if the inhibitory signal is transferred to adjacent cells in exosomes."
      }
    }
  },
  "llm_responses": [
    {
      "step": "llm_response",
      "timestamp": "2025-06-24T03:11:34.521601",
      "prompt": "Original description: During embryonic development, cardiac valves arise at specific regions in the cardiac endothelium that swell up due to enhanced extracellular matrix production (so-called endocardial cushions). An important extracellular matrix component that is produced by the endocardial cells is the glycosaminoglycan hyaluronan. A deficiency in hyaluronan synthesis results in a failure to form endocardial cushions and a loss of their cellularization by a process called endothelial-to-mesenchymal transformation. Expression of the major hyaluronan synthase Has2 is under the influence of both positive and negative regulators. MicroRNA-dependent degradation of Has2 is required to control extracellular hyaluronan levels and thereby the size of the endocardial cushions. In this article, we review the current literature on hyaluronan synthesis during cardiac valve formation and propose that a balanced activity of both positive and negative regulators is required to maintain the critical homeostasis of hyaluronan levels in the extracellular matrix and thereby the size of the endocardial cushions. The activating and inhibitory interactions between microRNA-23, Has2, and hyaluronan are reminiscent of a reaction\u2013diffusion system. Using a mathematical modeling approach we show that the system can produce a confined expression of hyaluronan, but only if the inhibitory signal is transferred to adjacent cells in exosomes.\n\nClarifications provided: \n\n\n    Return ONLY a JSON object with ontology annotations. Format all IDs and terms exactly as specified in the system message.",
      "system_message": "You are a biological modeling expert. Create structured ontology annotations based on the provided information. \n    Include relevant Cell Ontology, GO, and MeSH terms where applicable.\n    Return ONLY a JSON object with categories for different ontology types.\n    \n    Format requirements:\n    1. Category names must be exact:\n       - \"CellOntology\" (not \"Cell Ontology\" or \"Cell  Ontology\")\n       - \"GeneOntology\" (not \"Gene Ontology\" or \"Gene  Ontology\")\n       - \"MeSH\" (not \"MeSH Terms\" or \"MeSH  Terms\")\n    \n    2. Ontology IDs must be exact without spaces:\n       - Cell Ontology: \"CL:0000000\" (not \"CL : 000 000 0\")\n       - Gene Ontology: \"GO:0000000\" (not \"GO : 000 000 0\")\n       - MeSH: \"D000000\" (not \"D 000 000\")\n    \n    3. Term names must be exact without extra spaces:\n       - \"Epithelial\" (not \"Ep ith elial\")\n       - \"Mesenchymal\" (not \"Mes ench ym al\")\n    \n    Example format:\n    {\n        \"CellOntology\": [\n            {\n                \"id\": \"CL:0000000\",\n                \"term\": \"Epithelial\"\n            }\n        ],\n        \"GeneOntology\": [\n            {\n                \"id\": \"GO:0000000\",\n                \"term\": \"Cell Division\"\n            }\n        ],\n        \"MeSH\": [\n            {\n                \"id\": \"D000000\",\n                \"term\": \"Cell Proliferation\"\n            }\n        ]\n    }\n    \n    Do not include any explanations or thinking process.",
      "response": "<think>\nOkay, let's tackle this. The user wants me to create structured ontology annotations based on the provided biological information. The key here is to identify relevant terms from Cell Ontology (CL), Gene Ontology (GO), and MeSH. \n\nFirst, looking at the original description: it talks about cardiac valve development, endocardial cushions, endocardial cells, endothelial-to-mesenchymal transformation (EMT), hyaluronan synthesis, and microRNA-23 involved in regulating Has2. \n\nStarting with CellOntology. The endocardial cushions are mentioned, which are structures formed by endocardial cells. The Cell Ontology term for endocardial cell is CL:0002251. Also, endothelial-to-mesenchymal transformation involves cells changing from endothelial to mesenchymal. So mesenchymal cell would be CL:0008019.\n\nNext, GeneOntology. The process includes extracellular matrix production, so \"extracellular matrix organization\" (GO:0030198). EMT is \"endothelial to mesenchymal transition\" (GO:0060973). Hyaluronan biosynthesis is \"glycosaminoglycan biosynthetic process\" (GO:0006026), and microRNA activity would fall under \"gene silencing by miRNA\" (GO:0035195).\n\nFor MeSH terms, \"Endocardial Cushions\" is D004698. \"Hyaluronic Acid\" is D006820. \"MicroRNAs\" are D036342. And \"Extracellular Matrix\" is D005109. \n\nNeed to make sure all IDs are correctly formatted without spaces, and terms are exact. Let me check each term's ID. CL:0002251 for endocardial cell, CL:0008019 for mesenchymal. GO terms: 0030198, 0060973, 0006026, 0035195. MeSH D004698, D006820, D036342, D005109. \n\nYes, that seems to cover all the main elements from the text. No extra terms, just what's mentioned. Formatting the JSON exactly as specified, no extra spaces, correct category names. Should be good.\n</think>\n\n{\n    \"CellOntology\": [\n        {\n            \"id\": \"CL:0002251\",\n            \"term\": \"endocardial cell\"\n        },\n        {\n            \"id\": \"CL:0008019\",\n            \"term\": \"mesenchymal cell\"\n        }\n    ],\n    \"GeneOntology\": [\n        {\n            \"id\": \"GO:0030198\",\n            \"term\": \"extracellular matrix organization\"\n        },\n        {\n            \"id\": \"GO:0060973\",\n            \"term\": \"endothelial to mesenchymal transition\"\n        },\n        {\n            \"id\": \"GO:0006026\",\n            \"term\": \"glycosaminoglycan biosynthetic process\"\n        },\n        {\n            \"id\": \"GO:0035195\",\n            \"term\": \"gene silencing by miRNA\"\n        }\n    ],\n    \"MeSH\": [\n        {\n            \"id\": \"D004698\",\n            \"term\": \"Endocardial Cushions\"\n        },\n        {\n            \"id\": \"D006820\",\n            \"term\": \"Hyaluronic Acid\"\n        },\n        {\n            \"id\": \"D036342\",\n            \"term\": \"MicroRNAs\"\n        },\n        {\n            \"id\": \"D005109\",\n            \"term\": \"Extracellular Matrix\"\n        }\n    ]\n}"
    },
    {
      "step": "llm_response",
      "timestamp": "2025-06-24T03:11:59.057839",
      "prompt": "Generate a valid CompuCell3D simulation file based on these ontology annotations.\n    Return ONLY the Python code:\n\n{'CellOntology': {'mesenchymal cell (CL:0008019)', 'endocardial cell (CL:0002251)'}, 'GeneOntology': {'endothelial to mesenchymal transition (GO:0060973)', 'gene silencing by miRNA (GO:0035195)', 'extracellular matrix organization (GO:0030198)', 'glycosaminoglycan biosynthetic process (GO:0006026)'}, 'MeSH': {'Endocardial Cushions (D004698)', 'Extracellular Matrix (D005109)', 'Hyaluronic Acid (D006820)', 'MicroRNAs (D036342)'}}",
      "system_message": "You are a CompuCell3D expert. Generate a valid CompuCell3D simulation file.\n    Return ONLY the Python code without any additional text, explanations, or thinking process.\n    The code must include:\n    1. Required imports (CompuCellSetup, steppables)\n    2. A proper simulation class that inherits from steppables.SteppableBasePy\n    3. Required methods (__init__, start, step)\n    4. Basic cell types and parameters based on the ontology annotations",
      "response": "<think>\nOkay, I need to generate a valid CompuCell3D simulation file based on the given ontology annotations. Let's break down the requirements.\n\nFirst, the user wants imports: CompuCellSetup and steppables. I remember that in CompuCell3D, the basic setup includes importing those, and maybe other modules like sys or numpy if needed, but the user didn't specify, so I'll stick to the essentials.\n\nNext, a simulation class inheriting from steppables.SteppableBasePy. The class should have __init__, start, and step methods. The __init__ method usually calls the parent's init. The start method is for initial setup, and step runs each simulation step.\n\nLooking at the CellOntology: mesenchymal and endocardial cells. So I need to define these cell types. In CompuCell, that's done with self.cellTypeDict. Also, maybe set their properties like adhesion or volume.\n\nGeneOntology terms include processes like endothelial to mesenchymal transition (EMT), gene silencing by miRNA, ECM organization, and glycosaminoglycan synthesis. For the simulation, EMT could mean changing cell type from endocardial to mesenchymal. Maybe check for a condition in the step method and change the type if met. Gene silencing might involve a chemical field or a parameter affecting behavior. ECM and glycosaminoglycan processes could involve the extracellular matrix, so maybe a secretion field or matrix tracking.\n\nMeSH terms include Endocardial Cushions, Extracellular Matrix, Hyaluronic Acid, MicroRNAs. Hyaluronic acid is a glycosaminoglycan, so perhaps a secretion/uptake field for that. MicroRNAs could be modeled as a field influencing gene silencing, maybe affecting the transition rate in EMT.\n\nIn the start method, initialize cell types and maybe some initial cells. For ECM, set up a field like 'HA' for Hyaluronic Acid. The step method could handle EMT transitions, maybe based on a probability influenced by miRNA levels. Also, cells might secrete HA into the ECM.\n\nParameters: Set cell adhesion, volume, and lambda values. Maybe define a secretion rate for HA. Also, a probability for EMT transition, which could be modulated by a miRNA factor.\n\nWait, the user wants basic parameters based on the ontology. So I should include cell types, maybe volume constraints, adhesion, secretion, and a mechanism for EMT.\n\nPutting it all together: Import necessary modules, define the simulation class with init, start, step. In start, set up cell types and initial cells. In step, check each cell, maybe change type based on conditions. Include secretion of HA. Also, handle miRNA effect by adjusting transition probability.\n\nI should make sure all parts are included. The code should run without errors. Use the SteppableBasePy correctly. Assign proper cell types, maybe set up a few mesenchymal and endocardial cells initially. In the step method, loop through cells and apply the transition with some probability, maybe influenced by a miRNA field or parameter. Also, secrete HA into the ECM field.\n\nI need to avoid any extra explanations, just the code. Check that all required elements are there. Use correct CompuCell3D syntax for cell type definitions, fields, and steppable methods.\n</think>\n\n```python\nimport CompuCellSetup\nfrom PySteppables import SteppableBasePy, Dim3D\nimport sys\nimport random\n\nclass SimulationSteppable(SteppableBasePy):\n    def __init__(self, _simulator, _frequency=1):\n        super().__init__(_simulator, _frequency)\n        \n    def start(self):\n        # Define cell types\n        self.cellTypeDict = {\n            \"Endocardial\": self.registerCellType(\"Endocardial\"),\n            \"Mesenchymal\": self.registerCellType(\"Mesenchymal\")\n        }\n        \n        # Initialize extracellular matrix field\n        self.hyaluronic_acid = self.createFieldFloat(\"HA\", self.dim)\n        \n        # Set basic cell parameters\n        for cell_type in [self.cellTypeDict[\"Endocardial\"], self.cellTypeDict[\"Mesenchymal\"]]:\n            self.setCellTypeMFDCSV(cell_type, 20, 8, 200)\n            self.setCellTypeAdhesion(cell_type, 10)\n        \n        # Create initial cells\n        for _ in range(10):\n            x = random.randint(0, self.dim.x-1)\n            y = random.randint(0, self.dim.y-1)\n            self.cellField[x, y, 0] = self.newCell(self.cellTypeDict[\"Endocardial\"])\n        \n    def step(self, mcs):\n        # Endothelial to mesenchymal transition\n        for cell in self.cellList:\n            if cell.type == self.cellTypeDict[\"Endocardial\"]:\n                if random.random() < 0.01 * (1 + self.getConcentration(\"miRNA\", cell)/10):\n                    cell.type = self.cellTypeDict[\"Mesenchymal\"]\n                    cell.targetVolume = 30\n                    cell.lambdaVolume = 2\n                \n            # ECM organization and glycosaminoglycan secretion\n            if cell.type == self.cellTypeDict[\"Mesenchymal\"]:\n                self.hyaluronic_acid[cell.xCOM, cell.yCOM, cell.zCOM] += 0.1\n\nCompuCellSetup.registerSteppable(SimulationSteppable(CompuCellSetup.getSimulator()))\n```"
    }
  ],
  "outputs": {},
  "metadata": {
    "experiment_model_type": "reasoning",
    "model_type": "reasoning",
    "model_name": "deepseek-ai/deepseek-r1",
    "thinking_process": "<think>\nOkay, I need to generate a valid CompuCell3D simulation file based on the given ontology annotations. Let's break down the requirements.\n\nFirst, the user wants imports: CompuCellSetup and steppables. I remember that in CompuCell3D, the basic setup includes importing those, and maybe other modules like sys or numpy if needed, but the user didn't specify, so I'll stick to the essentials.\n\nNext, a simulation class inheriting from steppables.SteppableBasePy. The class should have __init__, start, and step methods. The __init__ method usually calls the parent's init. The start method is for initial setup, and step runs each simulation step.\n\nLooking at the CellOntology: mesenchymal and endocardial cells. So I need to define these cell types. In CompuCell, that's done with self.cellTypeDict. Also, maybe set their properties like adhesion or volume.\n\nGeneOntology terms include processes like endothelial to mesenchymal transition (EMT), gene silencing by miRNA, ECM organization, and glycosaminoglycan synthesis. For the simulation, EMT could mean changing cell type from endocardial to mesenchymal. Maybe check for a condition in the step method and change the type if met. Gene silencing might involve a chemical field or a parameter affecting behavior. ECM and glycosaminoglycan processes could involve the extracellular matrix, so maybe a secretion field or matrix tracking.\n\nMeSH terms include Endocardial Cushions, Extracellular Matrix, Hyaluronic Acid, MicroRNAs. Hyaluronic acid is a glycosaminoglycan, so perhaps a secretion/uptake field for that. MicroRNAs could be modeled as a field influencing gene silencing, maybe affecting the transition rate in EMT.\n\nIn the start method, initialize cell types and maybe some initial cells. For ECM, set up a field like 'HA' for Hyaluronic Acid. The step method could handle EMT transitions, maybe based on a probability influenced by miRNA levels. Also, cells might secrete HA into the ECM.\n\nParameters: Set cell adhesion, volume, and lambda values. Maybe define a secretion rate for HA. Also, a probability for EMT transition, which could be modulated by a miRNA factor.\n\nWait, the user wants basic parameters based on the ontology. So I should include cell types, maybe volume constraints, adhesion, secretion, and a mechanism for EMT.\n\nPutting it all together: Import necessary modules, define the simulation class with init, start, step. In start, set up cell types and initial cells. In step, check each cell, maybe change type based on conditions. Include secretion of HA. Also, handle miRNA effect by adjusting transition probability.\n\nI should make sure all parts are included. The code should run without errors. Use the SteppableBasePy correctly. Assign proper cell types, maybe set up a few mesenchymal and endocardial cells initially. In the step method, loop through cells and apply the transition with some probability, maybe influenced by a miRNA field or parameter. Also, secrete HA into the ECM field.\n\nI need to avoid any extra explanations, just the code. Check that all required elements are there. Use correct CompuCell3D syntax for cell type definitions, fields, and steppable methods.\n</think>",
    "cc3d_file_creation": {
      "python_code": "from cc3d.core.PySteppables import *\n\nimport CompuCellSetup\nfrom PySteppables import SteppableBasePy, Dim3D\nimport sys\nimport random\n\nclass SimulationSteppable(SteppableBasePy):\n    def __init__(self, _simulator, _frequency=1):\n        super().__init__(_simulator, _frequency)\n        \n    def start(self):\n        # Define cell types\n        self.cellTypeDict = {\n            \"Endocardial\": self.registerCellType(\"Endocardial\"),\n            \"Mesenchymal\": self.registerCellType(\"Mesenchymal\")\n        }\n        \n        # Initialize extracellular matrix field\n        self.hyaluronic_acid = self.createFieldFloat(\"HA\", self.dim)\n        \n        # Set basic cell parameters\n        for cell_type in [self.cellTypeDict[\"Endocardial\"], self.cellTypeDict[\"Mesenchymal\"]]:\n            self.setCellTypeMFDCSV(cell_type, 20, 8, 200)\n            self.setCellTypeAdhesion(cell_type, 10)\n        \n        # Create initial cells\n        for _ in range(10):\n            x = random.randint(0, self.dim.x-1)\n            y = random.randint(0, self.dim.y-1)\n            self.cellField[x, y, 0] = self.newCell(self.cellTypeDict[\"Endocardial\"])\n        \n    def step(self, mcs):\n        # Endothelial to mesenchymal transition\n        for cell in self.cellList:\n            if cell.type == self.cellTypeDict[\"Endocardial\"]:\n                if random.random() < 0.01 * (1 + self.getConcentration(\"miRNA\", cell)/10):\n                    cell.type = self.cellTypeDict[\"Mesenchymal\"]\n                    cell.targetVolume = 30\n                    cell.lambdaVolume = 2\n                \n            # ECM organization and glycosaminoglycan secretion\n            if cell.type == self.cellTypeDict[\"Mesenchymal\"]:\n                self.hyaluronic_acid[cell.xCOM, cell.yCOM, cell.zCOM] += 0.1\n\nCompuCellSetup.registerSteppable(SimulationSteppable(CompuCellSetup.getSimulator()))",
      "output_file": "experiments\\batch_reasoning_20250624_020624\\paper_12_Hyaluronan_A_20250624_020624\\run_2\\generated_cc3d_model.cc3d"
    }
  }
}